Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-9.

Wi J, Ko YG, Shin DH, et al. Prediction of Contrast-Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long-term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score. Clin Cardiol. 2013;36(1):46-53.

Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):491-8.

Raingruber B, Kirkland-walsh H, Chahon N, Kellermann M. Using the Mehran risk scoring tool to predict risk for contrast medium-induced nephropathy in patients undergoing percutaneous angiography. Crit Care Nurse. 2011;31(1):e17-22.

Abellás-sequeiros RA, Raposeiras-roubín S, Abu-assi E, et al. Mehran contrast nephropathy risk score: Is it still useful 10 years later?. J Cardiol. 2016;67(3):262-7.

Dr. Roxana Mehran

Mehran Score for Post-PCI Contrast Nephropathy

hypo

pump

anemia

diab

Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).

Mehran Score (Post-PCI Nephropathy)

The Mehran Score for Post-PCI Contrast Nephropathy predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).

Volume

CKD-EPI Equations for GFR

Kidney Failure Risk Calculator

MDRD GFR Equation

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function